Corticosteroids + Ustekinumab Aekn Interaction
Moderateinteraction on record
Description
Used concomitantly in approximately 40% and 50% of Crohn's disease and ulcerative colitis subjects respectively. Concomitant use did not appear to influence overall safety or efficacy of ustekinumab.
Source: NLP:ustekinumab-aekn